Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.We were part of an international effort to find the breast cancer genes in the 1990s when Myriad saw what we'd done, raised the extra £40m needed to name the gene, and beat us there.
Now, in addition to owning the patents on the gene tests, it wants to keep its database of DNA variations a trade secret. It will be increasingly important to know which sequence variations in DNA are significant for disease risk. The best way to do this will be through accumulating sequence and clinical data about individuals and their families – data that, through their testing, Myriad holds.
We should remember that Myriad's patents on the BRCA genes would have been difficult or impossible without building on a great deal of international publicly-funded research. Companies should be obliged to put such data in the public domain.
Professor Sir Bruce Ponder of Cambridge University led the research consortium that laid the groundwork for the discovery of the BRCA breast cancer genes
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments